Compulsory licensing: a mechanism in balancing the rights to patents and the need to protect health
The topic of Compulsory licensing (CL) is right in the centre of a huge controversy of intellectual property and the fundamental right to health. As nations attempt to increase pharma innovations, and at the same time to make life saving drugs affordable, CL emerges as the most appropriate legal solution. It is where governments permit […]
Global Drug Pricing Reforms and Their Commercial Fallout: A Legal Perspective On MFN and India-U.S. Pharma Trade
The U.S government revived the “Most Favoured Nation” i.e the MFN drug pricing policy in May 2025, aimed at curbing exorbitant medicine costs by tying U.S. drug prices to the lowest rates paid by developed nations. The move not only has rooted in trade law principles but has also sent ripples through the pharmaceutical world- […]
Ever Greening: An Abuse of the Patent System
“Drawing the line between improper attempts at evergreening and legitimate incremental innovation is a broad and difficult problem in patent law.” In the modern world, the drive for progress and higher living standards is constant. Science and technology are always evolving to meet these needs. However, what drives someone to work so hard to improve […]